AngioDynamics
AngioDynamics is a publicly traded medical technology company founded in 1988 and became independent in 2004. The company specializes in designing, manufacturing, and selling minimally invasive medical devices used primarily in vascular access, surgery, peripheral vascular disease, and oncology treatments. Its product portfolio includes diagnostic and therapeutic catheters, vascular access devices, and various ablation technologies. Notable offerings include the NanoKnife system, AngioVac vascular removal system, and Auryon laser atherectomy platform. AngioDynamics has expanded its range through strategic acquisitions, enhancing its market presence and product diversity. Headquartered in Queensbury, New York, AngioDynamics serves a wide customer base, including hospitals, interventional radiologists, oncologists, vascular surgeons, and dialysis centers worldwide. The company is committed to improving patient outcomes by providing effective, less invasive therapeutic options.
Work at AngioDynamics in HR or recruiting? Claim this page
Headcount trend
AngioDynamics went from 573 employees in Jul 2023 to 542 in Jun 2025. Jan to Jun 2025: 24 people joined, 31 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Executive compensation
Hiring now
See all jobsPeer reviews
Worked with someone at AngioDynamics?
Anonymous peer reviews on OffTheRecord
Similar companies
AngioDynamics FAQ
How many employees does AngioDynamics have?
AngioDynamics has about 542 employees, up 1.3% over the 3 months to Jun 2025.
What is AngioDynamics's revenue per employee?
AngioDynamics makes about $540K in revenue per employee, based on $292.5M annual revenue and 542 employees.
Is AngioDynamics a public company?
Yes. AngioDynamics is publicly traded under the ticker ANGO on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.